Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

McN 3716

Known as: McN-3716 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
We examined the dose response, time course and reversibility of the effect of methyl 2-tetradecylglycidate (McN-3716, methyl… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
2002
2002
We examined the effect of a clinically therapeutic dose of methyl 2-tetradecylglycidate (McN-3716, methyl palmoxirate, MEP) (2.5… Expand
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • figure 4
1997
1997
We examined the effect of a clinically therapeutic dose of methyl 2-tetradecylglycidate (McN-3716, methyl palmoxirate, MEP) (2.5… Expand
1993
1993
We examined the effect of the long-chain fatty acid oxidation blocker methyl palmoxirate (methyl 2-tetradecyloxiranecarboxylate… Expand
Highly Cited
1985
Highly Cited
1985
The pancreatic B-cell may represent a fuel-sensor organ, the release of insulin evoked by nutrient secretagogues being… Expand
1984
1984
The effect of the oral hypoglycemic agent methyl palmoxirate (methyl 2-tetradecylglycidate, McN-3716), a selective inhibitor of… Expand
Highly Cited
1979
Highly Cited
1979
The oral hypoglycemic agents methyl 2-tetradecylglycidate (McN-3716) and 2-tetradecylglycidic acid (McN-3802), synthesized in an… Expand
  • figure 2
  • figure 4
  • figure 3
  • figure 5
  • figure 6
Highly Cited
1979
Highly Cited
1979
Using isolated hepatocytes from fasted rats, the oral hypoglycemic agents, Z-tetradecylglycidic acid (McN3802) and its methyl… Expand
  • table I
  • figure 1
  • table II
  • figure 2
  • figure 3
Highly Cited
1978
Highly Cited
1978
A specific inhibitor of fatty acid oxidation, methyl 2-tetradecylglycidate (McN-3716) has been found to produce a dose dependent… Expand